Walleye Capital LLC Bristol Myers Squibb CO Put Options Transaction History

Walleye Capital LLC

14 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$39.66 - $51.75 $13 Million - $17 Million	-328,600 Reduced 52.53%	296,900 $15.4 Million
Q2 2024 Aug 14, 2024	BUY	$40.25 - $52.99 $14.2 Million - $18.7 Million	352,200 Added 128.87%	625,500 $26 Million
Q1 2024 May 15, 2024	SELL	$47.98 - $54.4 $6.9 Million - $7.83 Million	-143,900 Reduced 34.49%	273,300 $14.8 Million
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $1.74 Million - $2.08 Million	-35,900 Reduced 7.92%	417,200 $21.4 Million
Q3 2023 Nov 14, 2023	BUY	$57.89 - $64.73 $17.6 Million - $19.7 Million	304,700 Added 205.32%	453,100 $26.3 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $4.55 Million - $5.05 Million	71,400 Added 92.73%	148,400 $9.49 Million
Q1 2023 May 15, 2023	BUY	$65.71 - $74.53 $814,803 - $924,172	12,400 Added 19.2%	77,000 $5.34 Million
Q4 2022 Feb 14, 2023	SELL	$68.48 - $81.09 $2.7 Million - $3.2 Million	-39,500 Reduced 37.94%	64,600 $4.65 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $13,533 - $8 Million	104,100 New	104,100 $7.4 Million
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $4.47 Million - $6.5 Million	-96,400 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $871,017 - $1.14 Million	17,700 Added 22.49%	96,400 $6.19 Million
Q3 2019 Nov 14, 2019	BUY	$42.77 - $50.71 $1.58 Million - $1.88 Million	37,000 Added 88.73%	78,700 $3.99 Million
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $1.83 Million - $2.02 Million	41,000 Added 5857.14%	41,700 $1.89 Million
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $31,584 - $37,660	700 New	700 $33,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.